Gene-modified Cell Treatments Market Size, Share, and Industry Analysis, By Therapy Type (Chimeric Antigen Receptor T-cell therapy, T-cell Receptor T-cell Therapies, Chimeric Antigen Receptor-Natural Killer Cell Therapy, and Others), By Disease Indication (Oncology, Hematology, Autoimmune Disorders, Rare Diseases, and Others), By End User (Hospitals & Specialty Clinics, Academic & Research Institutes, and Biotechnology & Pharmaceutical Companies), and Regional Forecast, 2026-2034

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content:

1. Introduction
   1. Market Scope
   2. Market Segmentation
   3. Market Methodology
   4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   1. Market Drivers
   2. Market Restraints
   3. Market Opportunities 
   4. Market Trends
4. Key Insights
   1. Development of Gene-Modified Cell Therapy for New Disease Indications
   2. Regulatory Scenarios, By Key Countries/Regions
   3. Technological Advancements in the Gene-Modified Cell Therapy Market
   4. New Product Launches, By Key Players
   5. Pipeline Analysis, By Key Companies
   6. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
   7. Pricing & Reimbursement Landscape in the Gene-Modified Cell Therapy Market
   8. Manufacturing & Supply Chain Insights
   9. Investment & Funding Trends in the Market
5. Global Gene-modified Cell Treatments Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Therapy Type
      1. Chimeric Antigen Receptor T-cell Therapy
      2. T-cell Receptor T-cell Therapies
      3. Chimeric Antigen Receptor-Natural Killer Cell Therapy
      4. Others
   2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Oncology
      2. Hematology
      3. Autoimmune Disorders
      4. Rare Diseases
      5. Others
   3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Specialty Clinics
      2. Academic & Research Institutes
      3. Biotechnology & Pharmaceutical Companies
   4. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
6. North America Gene-modified Cell Treatments Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Therapy Type
      1. Chimeric Antigen Receptor T-cell Therapy
      2. T-cell Receptor T-cell Therapies
      3. Chimeric Antigen Receptor-Natural Killer Cell Therapy
      4. Others
   2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Oncology
      2. Hematology
      3. Autoimmune Disorders
      4. Rare Diseases
      5. Others
   3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Specialty Clinics
      2. Academic & Research Institutes
      3. Biotechnology & Pharmaceutical Companies
   4. Market Analysis, Insights and Forecast – By Country
      1. U.S. 
      2. Canada 
7.  Europe Gene-modified Cell Treatments Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Therapy Type
      1. Chimeric Antigen Receptor T-cell Therapy
      2. T-cell Receptor T-cell Therapies
      3. Chimeric Antigen Receptor-Natural Killer Cell Therapy
      4. Others
   2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Oncology
      2. Hematology
      3. Autoimmune Disorders
      4. Rare Diseases
      5. Others
   3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Specialty Clinics
      2. Academic & Research Institutes
      3. Biotechnology & Pharmaceutical Companies
   4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. UK
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe 
8. Asia Pacific Gene-modified Cell Treatments Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Therapy Type
      1. Chimeric Antigen Receptor T-cell Therapy
      2. T-cell Receptor T-cell Therapies
      3. Chimeric Antigen Receptor-Natural Killer Cell Therapy
      4. Others
   2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Oncology
      2. Hematology
      3. Autoimmune Disorders
      4. Rare Diseases
      5. Others
   3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Specialty Clinics
      2. Academic & Research Institutes
      3. Biotechnology & Pharmaceutical Companies
   4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific 
9. Latin America Gene-modified Cell Treatments Market Analysis, Insights and Forecast, 2019-2032
   1. Market Analysis, Insights and Forecast – By Therapy Type
      1. Chimeric Antigen Receptor T-cell Therapy
      2. T-cell Receptor T-cell Therapies
      3. Chimeric Antigen Receptor-Natural Killer Cell Therapy
      4. Others
   2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Oncology
      2. Hematology
      3. Autoimmune Disorders
      4. Rare Diseases
      5. Others
   3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals & Specialty Clinics
      2. Academic & Research Institutes
      3. Biotechnology & Pharmaceutical Companies
   4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil 
      2. Mexico 
      3. Rest of Latin America
10. Middle East & Africa Gene-modified Cell Treatments Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Therapy Type
       1. Chimeric Antigen Receptor T-cell Therapy
       2. T-cell Receptor T-cell Therapies
       3. Chimeric Antigen Receptor-Natural Killer Cell Therapy
       4. Others
    2. Market Analysis, Insights and Forecast – By Disease Indication
       1. Oncology
       2. Hematology
       3. Autoimmune Disorders
       4. Rare Diseases
       5. Others
    3. Market Analysis, Insights and Forecast – By End User
       1. Hospitals & Specialty Clinics
       2. Academic & Research Institutes
       3. Biotechnology & Pharmaceutical Companies
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
       1. South Africa
       2. GCC 
       3. Rest of Middle East & Africa
11. Competitive Analysis
    1. Global Market Share Analysis (2024)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
       1. Gilead Sciences, Inc.
       2. Bluebird Bio, Inc. 
       3. CRISPR Therapeutics AG 
       4. Novartis AG 
       5. Allogene Therapeutics, Inc. 
       6. Sangamo Therapeutics, Inc. 
       7. Other Prominent Players